The upregulation of immune checkpoint molecules occurs when cancer cells express proteins like cytotoxic T lymphocyte-associated protein 4 (CTLA-4) and programmed cell death ligand 1 (PD-L1) to bind their inhibitory receptors in immune cells, avoiding cancer cell destruction by T cells [159]. This evidence concerns the gene CTLA4 and cancer.